Press release
Hereditary Angioedema - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Hereditary Angioedema
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies : https://www.globalinsightservices.com/request-sample/GIS31156
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called C1 inhibitor.
Symptoms are severe abdominal pain and cramping, dehydration, diarrhea and shock, hoarse voice, difficulty swallowing, and difficulty breathing.
Read more about Hereditary Angioedema Pipeline Insight here: https://www.globalinsightservices.com/reports/hereditary-angioedema-drug-pipeline-landscape/
Report Highlights
Global Insight Service's, Hereditary Angioedema - Drug Pipeline Landscape, 2022 report provides an overview of the Hereditary Angioedema pipeline drugs. This report covers detailed insights on Hereditary Angioedema drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Hereditary Angioedema pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players
• Astria Therapeutics Inc
• Attune Pharmaceuticals
• BioMarin Pharmaceutical
• Bridge Medicines LLC
• CAMP4 Therapeutics Corp
• CSL Behring
• Curacle Co Ltd
• Intellia Therapeutics
• Ionis Pharmaceuticals Inc
• Kalvista Pharmaceuticals Ltd
• Octapharma AG
• Pharming Technologies B.V
• Pharvaris Netherlands B.V
• Spark Therapeutics Inc
• Verseon Corp
For In-Depth Competitive Analysis, Purchase this Report : https://www.globalinsightservices.com/checkout/single_user/GIS31156
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail:info@globalinsightservices.com
Phone: +1-833-761-1700
Website:https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema - Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2946951 • Views: …
More Releases from Global Insight Services
Public Key Infrastructure (PKI) Market to Reach $12.6 Billion by 2034 With 9.9% …
The Public Key Infrastructure (PKI) Market plays a critical role in the global cybersecurity landscape, enabling organizations to secure electronic communications and digital transactions. By providing a framework for encryption, authentication, and digital certificates, PKI ensures trust, confidentiality, and data integrity across industries. From banking and government services to healthcare and manufacturing, PKI has become essential in a world increasingly reliant on digital technologies. As enterprises accelerate digital transformation, the…
Fish Sauce Market Grows From $2.2 Billion in 2024 Amid Rising Demand for Authent …
The Fish Sauce Market has long been an integral part of Asian culinary traditions, particularly in countries such as Vietnam and Thailand. Made from fermented fish and salt, this flavorful condiment has been a staple for centuries, adding depth and umami to countless dishes. Today, the Fish Sauce Market is expanding far beyond its roots, finding its way into kitchens across North America, Europe, and beyond. With the rising global…
Breath Analyzer Market Is Anticipated To Expand From $4.1 Billion In 2024 To $9. …
Market Overview
The Breath Analyzer Market is gaining remarkable traction worldwide as demand for alcohol detection and health monitoring tools continues to rise. These devices, designed to measure blood alcohol content (BAC) through breath samples, have become indispensable in law enforcement, healthcare, and workplace safety. The market is projected to expand from $4.1 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of 9.1%. This growth is fueled…
Web Hosting Services Market Is Anticipated To Expand From $83.99 Billion In 2024 …
Market Overview
The Web Hosting Services Market is evolving rapidly as businesses and individuals continue to strengthen their online presence. Hosting services act as the backbone of the digital economy, providing the infrastructure that powers websites, e-commerce platforms, and digital applications. The industry covers a wide range of offerings, including shared hosting, dedicated hosting, virtual private servers (VPS), and cloud hosting. Each solution caters to different customer needs, from small businesses…
More Releases for Hereditary
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.
Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
